Butane

Butane

SCHEMBL2364892

CCCC.COc1cc(C(=O)N2CCC[C@H]2C=O)c([N+](=O)[O-])cc1OCCCCBr

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
HTT P42858 1/20 0.38
ALDH1A1 P00352 4/20 0.38
POLB P06746 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.35
HSD17B10 Q99714 1/20 0.35
LMNA P02545 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPC1 O15118 1/20 0.35
CYP3A4 P08684 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL3896794 0.99 KDM4E (0.40) KDM4EHTTALDH1A1POLBMAPT
Butane SCHEMBL2364965 0.97 KDM4E (0.41) KDM4EHTTALDH1A1POLBMAPT
SCHEMBL12985731 0.97 KDM4E (0.42) KDM4EHTTALDH1A1POLBMAPT
SCHEMBL14889460 0.96 KDM4E (0.41) KDM4EHTTALDH1A1POLBMAPT
Butane SCHEMBL2364882 0.95 KDM4E (0.41) KDM4EHTTALDH1A1POLBHPGD
SCHEMBL14889404 0.95 KDM4E (0.43) KDM4EHTTALDH1A1POLBMAPT
SCHEMBL17930846 0.92 KDM4E (0.43) KDM4EHTTALDH1A1POLBMAPT
Butane SCHEMBL3273854 0.90 KDM4E (0.42) KDM4EHTTALDH1A1POLBLMNA
SCHEMBL17930826 0.89 KDM4E (0.43) KDM4EHTTALDH1A1POLBMAPT
Butane SCHEMBL6362180 0.88 NPC1 (0.39) KDM4EHTTALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761537-B1 PYRROLO[2,1-C][1,4]BENZODIAZEPINE-NAPTHALIMIDE CONJUGATES LINKED THROUGH PIPERAZINE MOIETY AND PROCESS FOR PREPARATION THEREOF COUNCIL SCIENT IND RES (IN) 2011-08-03 EP disclosed
EP-1608664-B1 NON-CROSS-LINKING PYRROLO[2,1-C][1,4]BENZODIAZEPINES AS POTENTIAL ANTITUMOUR AGENTS AND PROCESS THEREOF COUNCIL SCIENT IND RES (IN) 2009-01-28 EP disclosed
EP-1761537-A1 PYRROLO[2,1-C][1,4]BENZODIAZEPINE-NAPTHALIMIDE CONJUGATES LINKED THROUGH PIPERAZINE MOIETY AND PROCESS FOR PREPARATION THEREOF Council of Scientific and Industrial Research (IN) 2007-03-14 EP disclosed
WO-2006003670-A1 PYRROLO[2,1-C][1,4]BENZODIAZEPINE-NAPTHALIMIDE CONJUGATES LINKED THROUGH PIPERAZINE MOIETY AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-01-12 WO disclosed
US-20060003994-A1 PYRROLO[2,1-C][1,4]BENZODIAZEPINE-NAPTHALIMIDE CONJUGATES LINKED THROUGH PIPERAZINE MOIETY AND PROCESS FOR PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2006-01-05 US disclosed
US-6979684-B1 Pyrrolo[2,1-c][1,4]benzodiazepine-napthalimide conjugates linked through piperazine moiety and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-12-27 US disclosed
US-20050222133-A1 PROCESS FOR PREPARING PYRROLO[2, 1-C] [1,4] BENZODIAZEPINE HYBRIDS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH 2005-10-06 US disclosed
US-6951853-B1 Process for preparing pyrrolo[2, 1-c] [1,4] benzodiazepine hybrids COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-10-04 US disclosed
WO-2005063759-A1 PROCESS FOR PREPARING PYRROLO[2, 1-c] [1, 4] BENZODIAZEPINE HYBRIDS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-07-14 WO disclosed
US-6884799-B2 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-04-26 US disclosed
US-20040192679-A1 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192679-A1 Non-cross-linking pyrrolo[2,1-c][1,4]benzodiazepines and process thereof GABRA1, GABRA4, GABRA5 KDM4E 632/4885HTT 3770/4885ALDH1A1 362/4885
US-20050222133-A1 PROCESS FOR PREPARING PYRROLO[2, 1-C] [1,4] BENZODIAZEPINE HYBRIDS PBRM1, GABRP, GABRA4 KDM4E 740/4885HTT 3614/4885ALDH1A1 1305/4885
US-20060003994-A1 PYRROLO[2,1-C][1,4]BENZODIAZEPINE-NAPTHALIMIDE CONJUGATES LINKED THROUGH PIPERAZINE MOIETY AND PROCESS FOR PREPARATION THEREOF GABRA5, GABRA1, GABRP KDM4E 1524/4885HTT 2225/4885ALDH1A1 468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.